BioNTech SE
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About BNTX
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Find out what a historical investment in BioNTech SE would be worth today using our BNTX stock calculator.
$28.93B
-
0.00%
6.44M
$118.73
$93.17
$118.73
$131.49
$76.53
Ready to start your investing journey with Stake?
Open an accountBNTX FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in BNTX
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in BNTX
on Stake
Buy BNTX from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of BNTX from only US$10 with fractional shares
